Mark Pykett

750 total citations
21 papers, 517 citations indexed

About

Mark Pykett is a scholar working on Oncology, Molecular Biology and Clinical Biochemistry. According to data from OpenAlex, Mark Pykett has authored 21 papers receiving a total of 517 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Molecular Biology and 5 papers in Clinical Biochemistry. Recurrent topics in Mark Pykett's work include Metabolism and Genetic Disorders (5 papers), Mesenchymal stem cell research (4 papers) and Biotin and Related Studies (4 papers). Mark Pykett is often cited by papers focused on Metabolism and Genetic Disorders (5 papers), Mesenchymal stem cell research (4 papers) and Biotin and Related Studies (4 papers). Mark Pykett collaborates with scholars based in United States and Taiwan. Mark Pykett's co-authors include Michael Rosenzweig, Maureen E. Murphy, James R. Bagley, Douglas Marks, Donna L. George, Ivona T. Olszak, Helen Kim, Naheed Banu, Richard H. Evans and F. James Primus and has published in prestigious journals such as Nature Biotechnology, Neurology and Human Molecular Genetics.

In The Last Decade

Mark Pykett

20 papers receiving 509 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Pykett United States 12 155 125 121 112 108 21 517
Steve Perkins United States 10 154 1.0× 181 1.4× 146 1.2× 124 1.1× 41 0.4× 16 540
Lucia Cuppini Italy 10 130 0.8× 116 0.9× 335 2.8× 40 0.4× 130 1.2× 17 549
PY Dietrich Switzerland 8 92 0.6× 91 0.7× 90 0.7× 79 0.7× 19 0.2× 13 380
Frank Schüler Germany 13 254 1.6× 234 1.9× 290 2.4× 84 0.8× 21 0.2× 37 824
Vashendriya V.V. Hira Netherlands 17 309 2.0× 204 1.6× 285 2.4× 41 0.4× 59 0.5× 24 673
Sarah Ridge Ireland 4 258 1.7× 227 1.8× 192 1.6× 49 0.4× 53 0.5× 5 636
Daniel Trageser United States 6 277 1.8× 190 1.5× 201 1.7× 124 1.1× 29 0.3× 8 629
Michael Jeffrey Cho United States 7 261 1.7× 334 2.7× 114 0.9× 43 0.4× 79 0.7× 8 779

Countries citing papers authored by Mark Pykett

Since Specialization
Citations

This map shows the geographic impact of Mark Pykett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Pykett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Pykett more than expected).

Fields of papers citing papers by Mark Pykett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Pykett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Pykett. The network helps show where Mark Pykett may publish in the future.

Co-authorship network of co-authors of Mark Pykett

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Pykett. A scholar is included among the top collaborators of Mark Pykett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Pykett. Mark Pykett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Chien, Yin‐Hsiu, Ni‐Chung Lee, Sheng‐Hong Tseng, et al.. (2019). AGIL-AADC Gene Therapy Results in Sustained Improvements in Motor and Developmental Milestones Over 5 Years in Children With AADC Deficiency (P4.6-058). Neurology. 92(15_supplement). 1 indexed citations
4.
Chien, Yin‐Hsiu, Sheng‐Hong Tseng, Chun‐Hwei Tai, et al.. (2019). AGIL-AADC gene therapy results in sustained improvements in motor and developmental milestones through 5 years in children with AADC deficiency. Journal of the Neurological Sciences. 405. 27–27. 1 indexed citations
5.
Chien, Yin‐Hsiu, Ni‐Chung Lee, Sheng‐Hong Tseng, et al.. (2018). Gene Therapy in Children with AADC Deficiency with AGIL-AADC Leads to De Novo Dopamine Production and Sustained Improvement in Motor Milestones over 5 Years (S29.008). Neurology. 90(15_supplement). 2 indexed citations
6.
Pykett, Mark, et al.. (2010). Streamlining your business for success. PubMed. 29(2). 110–2. 1 indexed citations
7.
Marshall, Deborah, James R. Bagley, Phong T. Le, et al.. (2003). T Cell Generation Including Positive and Negative Selection Ex Vivo in a Three-Dimensional Matrix. Journal of Hematotherapy & Stem Cell Research. 12(5). 565–574. 13 indexed citations
8.
Pykett, Mark, et al.. (2003). Expansion of HPCs from cord blood in a novel 3D matrix. Cytotherapy. 5(6). 490–499. 46 indexed citations
9.
Banu, Naheed, et al.. (2001). CYTOKINE-AUGMENTED CULTURE OF HAEMATOPOIETIC PROGENITOR CELLS IN A NOVEL THREE-DIMENSIONAL CELL GROWTH MATRIX. Cytokine. 13(6). 349–358. 45 indexed citations
10.
Poznansky, Mark C., Richard H. Evans, Russell B. Foxall, et al.. (2000). Efficient generation of human T cells from a tissue-engineered thymic organoid. Nature Biotechnology. 18(7). 729–734. 116 indexed citations
11.
Bagley, James R., Michael Rosenzweig, Douglas Marks, & Mark Pykett. (1999). Extended culture of multipotent hematopoietic progenitors without cytokine augmentation in a novel three-dimensional device. Experimental Hematology. 27(3). 496–504. 62 indexed citations
12.
Pykett, Mark, et al.. (1998). Differential p53, p21, mdm2 and Rb regulation in glioma cell lines that overexpress wild-type p53.. International Journal of Oncology. 13(2). 213–6. 9 indexed citations
13.
Pykett, Mark, John E. Landers, & Donna L. George. (1997). Expression patterns of the p53 tumor suppressor gene and the mdm2 proto-oncogene in human meningiomas. Journal of Neuro-Oncology. 32(1). 39–44. 14 indexed citations
14.
15.
Pykett, Mark, Edouard I. Azzam, & John B. Little. (1997). Differential regulation of cdk2 and cyclin D1 in irradiated human glioma cells. International Journal of Oncology. 10(1). 93–9. 2 indexed citations
16.
Pykett, Mark, et al.. (1994). The neurofibromatosis 2 (NF2) tumor suppressor gene encodes multiple alternatively spliced transcripts. Human Molecular Genetics. 3(4). 559–564. 57 indexed citations
17.
Pykett, Mark, et al.. (1994). Loss of chromosome 8p sequences in human breast carcinoma cell lines. Cancer Genetics and Cytogenetics. 76(1). 23–28. 14 indexed citations
18.
Pykett, Mark, et al.. (1994). Identification of a microsatellite instability phenotype in meningiomas.. PubMed. 54(24). 6340–3. 21 indexed citations
19.
Modiano, Jaime F., Yasuo Kokai, David B. Weiner, et al.. (1991). Progesterone augments proliferation induced by epidermal growth factor in a feline mammary adenocarcinoma cell line. Journal of Cellular Biochemistry. 45(2). 196–206. 24 indexed citations
20.
Sharkey, Robert M., et al.. (1987). Radioimmunotherapy of the GW-39 human colonic tumor xenograft with 131I-labeled murine monoclonal antibody to carcinoembryonic antigen.. PubMed. 47(21). 5672–7. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Steve Perkins Breakdown of academic impact, for papers by Lucia Cuppini Breakdown of academic impact, for papers by PY Dietrich Breakdown of academic impact, for papers by Frank Schüler Breakdown of academic impact, for papers by Vashendriya V.V. Hira Breakdown of academic impact, for papers by Sarah Ridge Breakdown of academic impact, for papers by Daniel Trageser Breakdown of academic impact, for papers by Michael Jeffrey Cho
Rankless by CCL
2026